M. Hassan-Zahraee

E. Peeva, S. Danese, K. Hung, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy Biomarkers

Shanrong Zhao, Baohong Zhang, D. Ziemek, 2019, Journal of Crohn's & colitis.

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

S. Vermeire, J. S. Kim, R. Clare, 2017, The Lancet.

The delayed hypersensitivity response and host resistance in surgical patients. 20 years later.

J. Meakins, N. Christou, M. Hassan-Zahraee, 1995 .

Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis

Zhan Ye, M. Baniecki, S. Danese, 2021, Inflammatory bowel diseases.

Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study

T. Hibi, R. Clare, M. Saruta, 2020, Intestinal research.

First‐in‐human, randomized dose‐escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF‐06480605 in healthy subjects

K. Hung, C. Banfield, I. Bhattacharya, 2019, British journal of clinical pharmacology.

The Delayed Hypersensitivity Response and Host Resistance in Surgical Patients: 20 Years Later

J. Meakins, N. Christou, M. Hassan-Zahraee, 1995, Annals of surgery.

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study.

E. Peeva, W. Sandborn, S. Danese, 2023, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Anti-MAdCAM-1 Antibody (PF-00547659) for Active Refractory Crohn's Disease: Results of the OPERA study

W. Reinisch, X. Hébuterne, J. Claus, 2015 .

Blockade of cytosolic phospholipase A2α prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses

M. Leach, Takao Shimizu, J. D. Clark, 2008, Journal of Neuroimmunology.

Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn’s Disease

Steven W. Martin, R. Clare, Baohong Zhang, 2017, Journal of Crohn's & colitis.

Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses.

E. Peeva, M. Hassan-Zahraee, Zhan Ye, 2024, Experimental dermatology.